Academic literature on the topic 'Biliary tract disease'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Biliary tract disease.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Biliary tract disease"
Bates, Daniel M., and George W. Girvin. "Biliary tract disease." American Journal of Surgery 153, no. 6 (June 1987): 532–34. http://dx.doi.org/10.1016/0002-9610(87)90149-8.
Full textKarrer, F. M., Roberta J. Hall, Barbara A. Stewart, and John R. Lilly. "Congenital Biliary Tract Disease." Surgical Clinics of North America 70, no. 6 (December 1990): 1403–18. http://dx.doi.org/10.1016/s0039-6109(16)45291-6.
Full textKnisely, A. S. "Paediatric biliary-tract disease." Current Diagnostic Pathology 8, no. 3 (June 2002): 152–59. http://dx.doi.org/10.1054/cdip.2002.0110.
Full textRicketts, Richard R. "Congenital biliary tract disease." Journal of Pediatric Surgery 26, no. 7 (July 1991): 871. http://dx.doi.org/10.1016/0022-3468(91)90207-a.
Full textO’Connor, Owen J., Siobhan O’Neill, and Michael M. Maher. "Imaging of Biliary Tract Disease." American Journal of Roentgenology 197, no. 4 (October 2011): W551—W558. http://dx.doi.org/10.2214/ajr.10.4341.
Full textMcEvoy, Colston F., and Frederick J. Suchy. "BILIARY TRACT DISEASE IN CHILDREN." Pediatric Clinics of North America 43, no. 1 (February 1996): 75–98. http://dx.doi.org/10.1016/s0031-3955(05)70398-9.
Full textBlaser, Martin J. "Helicobacters and biliary tract disease." Gastroenterology 114, no. 4 (April 1998): 840–42. http://dx.doi.org/10.1016/s0016-5085(98)70598-0.
Full textCello, John P. "AIDS-Related Biliary Tract Disease." Gastrointestinal Endoscopy Clinics of North America 8, no. 4 (October 1998): 963–73. http://dx.doi.org/10.1016/s1052-5157(18)30242-3.
Full textRai, Rudra, and Anthony N. Kalloo. "Biliary Tract Disease in Pregnancy." Journal SOGC 19, no. 10 (September 1997): 1075–81. http://dx.doi.org/10.1016/s0849-5831(97)80043-2.
Full textYates, Munford R., and Todd H. Baron. "BILIARY TRACT DISEASE IN PREGNANCY." Clinics in Liver Disease 3, no. 1 (February 1999): 131–46. http://dx.doi.org/10.1016/s1089-3261(05)70058-1.
Full textDissertations / Theses on the topic "Biliary tract disease"
Warburton, Richard. "A microbiological assessment of the human biliary tract in health and disease." Thesis, University of East Anglia, 2017. https://ueaeprints.uea.ac.uk/67133/.
Full textCheung, Yim, and 張艷. "Comparative analysis of metallic stenting versus surgical bypass in the management of malignant biliary obstruction." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/206556.
Full textpublished_or_final_version
Medicine
Master
Master of Medical Sciences
Vilhordo, Daniel Weiss. "Dados histopatológicos e sobrevida em adenocarcinomas da ampola de Vater." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2012. http://hdl.handle.net/10183/60750.
Full textBackground / Objectives: The prognosis of patients with ampullary adenocarcinomas can be influenced by such factors as pTNM stage and histopathological variables, such as intestinal or pancreatobiliary patterns. The characterization of these patterns can be facilitated by the expression of cytokeratins 7 (CK7) and 20 (CK20) and caudal-related homeobox gene 2 (CDX2). The aim of the present study was to analyze the association between the histopathological characteristics and the survival of patients with ampullary adenocarcinomas, as well as the association between the histopathological patterns and CK7, CK20 and CDX2 expression. Methods: This retrospective cohort study was performed at the Clinics Hospital of Porto Alegre between 2000 and 2011 and examined the histopathological data, pTNM stage, histopathological patterns, immunohistochemical expression patterns and survival of patients with ampullary adenocarcinomas. Results: The sample patient population consisted of 65 ampullary carcinomas. Of these carcinoma samples, an intestinal pattern was observed for 46, a pancreatobiliary pattern was observed for 16 and other patterns were observed 3 of the samples. The 5-year survival rate for patients following pancreaticoduodenectomy (n = 47) was 27%. From the univariate analysis, the following variables were associated with shorter survival times: the presence of 2 or more metastatic lymph nodes; positive lymph node ratio (LR) ≥ 20%; stage IIB or greater; high-grade tumors; and lymphovascular invasion. From the multivariate analysis, lymph node metastases and a LR ≥ 20% were shown to influence survival significantly. Conclusions: Lymph node metastases were associated with poor patient prognoses, although no association was found between the histopathological pattern and immunohistochemical expression.
Grieve, Andrew. "Does the aminotransferase aspartate to platelet ratio index (APRI) value at the time of kasai portoenterostomy show any relationship to long-term outcome in patients with Biliary Atresia." Thesis, 2014.
Find full textBiliary atresia (BA) is characterised by a progressive obliterative cholangiopathy. If surgical treatment by a Kasai Portoenterostomy (KP) is undertaken early on in life there is the potential for successful bile drainage. The natural disease progression without intervention results in fibrosis and cirrhosis, necessitating liver transplantation before two years of life. Despite the advances in the management of biliary atresia over the recent decades we still do not have a good indicator of which patients will do well after surgery and which will require further intervention for their liver dysfunction. There are many clinical and serological indicators that suggest liver failure, but liver histology remains the gold standard indicating the extent of liver damage. This is, however, being slowly replaced by various new less-invasive biological markers, including the Aminotransferase Aspartate to Platelet Ratio Index (APRi). This study looks at this biological marker for patients with biliary atresia with reference to their level of disease at the time of surgery and whether it is a prognostic tool for long-term outcomes in this group of patients.
Chuang, Shu-Hung, and 莊樹宏. "Developing single-incision laparoscopic surgery with conventional instruments for biliary tract disease." Thesis, 2015. http://ndltd.ncl.edu.tw/handle/60353445584512586062.
Full text國立交通大學
生物科技學系
103
Cholecystectomy, surgical removal of the diseased gallbladder, is one of the most common surgical procedures. While laparoscopic cholecystectomy (LC) becomes the standard procedure to treat benign gallbladder disease since 1990s, open cholecystectomy (OC) serves as a converted procedure in case patient safety is doubtful in difficult laparoscopic operations or a salvage procedure for patients who can’t tolerate a laparoscopic operation owing to poor general conditions. Common bile duct exploration is a well-established treatment option for choledocholithiasis alternative to retrograde endoscopic cholangiopancreatography (ERCP) with endoscopic sphincterotomy (ES). In the laparoscopic era, however, the adoption of laparoscopic common bile duct exploration (LCBDE) is limited due to the technical complexity. Single-incision laparoscopic surgery (SILS) which is also known as laparoendoscopic single-site (LESS) surgery has been applied in various fields to minimize the traumatic effects in recent two decades. We developed single-incision laparoscopic cholecystectomy (SILC) with conventional straight instruments as a step-by-step evolution of three-incision laparoscopic cholecystectomy (3ILC) and two-incision laparoscopic cholecystectomy (2ILC) in March 2010. A retrospective comparative study including our first 33 SILCs, 10 2ILCs, and 24 3ILCs showed SILC is feasible and safe for selective patients with uncomplicated benign gallbladder diseases compared to conventional multi-incision LC. Less postoperative pain and better cosmesis are the potential benefits but longer operative time is the drawback. Since May 2010, we began to adopt SILC as an optional procedure for acute cholecystitis. Our retrospective study comparing 62 SILCs and 46 3ILCs for acute cholecystitis revealed SILC is as safe and efficacious as traditional multi-incision LC for selective patients with complicated gallbladder diseases providing a low threshold for procedure conversion can be maintained. The complication rate is low and the major benefit for patients is faster recovery. After 73 SILCs (52 for uncomplicated diseases and 21 for complicated ones) were accomplished with three (4.1%) Clavien-Dindo classification grade I complications, we offered this technique to all the patients with benign gallbladder diseases as a routine procedure in March 2012. Our observational study comprising 200 consecutive SILCs revealed routine SILC for benign gallbladder diseases is safe and feasible in the experienced phase. According to the learning curve analysis, practicing SILC for uncomplicated gallbladder diseases helps to achieve competence in this technique for complicated diseases. Male gender and complicated gallbladder diseases were associated with a higher procedure conversion rate and aged patients were more liable to complications. Single-incision laparoscopic common bile duct exploration (SILCBDE), an innovative technique we developed in July 2012, has become the standard procedure for bile duct stone clearance by our clinical practice. A preliminary retrospective comparative study showed SILCBDE is safe and effective compared to conventional multi-incision laparoscopic common bile duct exploration (LCBDE). The potential benefits of this novel technique other than the well-known cosmetic advantage need further investigations.
Hu, Kuang-Chun, and 胡光濬. "Clinical Presentations of Different Aging Cohort with Biliary Tract Stone diseases." Thesis, 2013. http://ndltd.ncl.edu.tw/handle/06158341573926723132.
Full text國立臺灣大學
臨床醫學研究所
101
BACKGROUND: The prevalence of gallstone disease in the general population was 5.3-10% in Taiwan. Common bile duct (CBD) stones would develop in about 10%-20% of patients with gallstones. The role of clinical symptoms, trans-abdominal ultrasound scan (USS) and liver function tests (LFTs) in evaluating common bile duct(CBD) stones in patients with suspected pancreatobiliary disease has been studied widely. However, it is not clear whether these predictive models are useful in different aging cohort population. OBJECTIVES: To investigate the clinical symptoms and signs, trans-abdominal ultrasonographic findings, LFTs and endoscopic retrograde cholangiopancreatography(ERCP) findings in different aging cohort patients with and without CBD stones. METHODS: The medical records of patients aged from 18 year-old or older who underwent USS and ERCP from July 2004 to June 2008 were collected. Four hundred thirty-three patients with pancreatobiliary diseases divided into cohorts according to decades as young(Y, n= 143), young-old (YO, 65–74, n=153), old-old (OO, 75–84, n=88), and very-old (VO, ≥85, n=32). Clinical symptoms, biochemical liver tests, trans- abdominal ultrasonographic findings and ERCP results in these 4 groups were demonstrated and compared. The categorical variables of the groups were compared by Chi-square analysis. The significance of the mean differences between patients with and without stones was evaluated by Student''s t test. RESULTS: Four hundred thirty-three patients who received USS and ERCP procedures were included this study. Young and YO group patients were more likely to develop symptoms such as biliary colic when they had CBD stones. Mean serum AST level (205.32±213.60 vs 79.47±126.53, p<0.05) and ALT level (305.14±218.60 vs 100.65±128.72, p<0.05 ) were significant higher in Young groups patient with CBD stones than those without CBD stones. The proportion of abnormal serum AST and ALT were significant greater in Young, YO and OO groups patient with CBD stones than without CBD stones. Mean value and abnormal proportion of alkaline phosphatase (ALK-P) was higher in YO patients with CBD stone than without CBD stone (YO: 75.8%; OO: 50%; p=0.005). Sensitivity of USS for CBD stones in Young: 0.15; YO: 0.45; OO: 0.57; VO: 0.68. Accuracy of USS for detected CBD stone in Young: 48%; YO: 62.5%; OO: 70.1%; VO: 71.4%. Higher biliary pancreas malignancy rate might see in patients without CBD stone (Young: 18.6%; YO: 25%; OO: 21% VO: 23%). CONCLUSION: Combined evaluation of biochemical and USS findings may help predict the presence of CBD stones. In Young, Young-old and Old-old patients with CBD stones, the incidences of abnormal LFTs were higher. USS sensitivity and accuracy for CBD stone presentation was increased by aging.
Wu, Hui-Chun, and 吳惠君. "The Proteomic Analysis of Human Bile inPatients with Biliary Tract Diseases." Thesis, 2005. http://ndltd.ncl.edu.tw/handle/35693424224769360334.
Full text國立成功大學
醫學檢驗生物技術學系
93
Both benign and malignant biliary tract disease can cause biliary obstruction. The differential diagnosis between them is difficult as the neoplastic foci may be trivial and combined with other benign diseases. Early detection of biliary cancers is important for the survival of patients as the advanced biliary cancers usually involve the bile ducts and vessels, which render the surgical resection impossible. Various markers have been used for differential diagnosis of biliary obstruction. However, they are neither sensitive nor specific. A novel marker with a better diagnostic efficacy is therefore needed. Nitration of proteins, a post-translational modification of proteins resulting from nitrosative stress, may play a role in the pathogenesis of various diseases. The aim of this study is to construct the maps of biliary proteome in order to search new biomarkers for differential diagnosis and studying pathogenesis of various biliary tract diseases by differential proteomic analysis and nitrotyrosine immunoblotting. Biliary proteins were separated by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE). Composite samples were prepared by pooling biles from nine gallstone and nine biliay tract cancer patients. The albumin and lipid were removed before analysis to reduce the interference and achieve a better resolution. For the nitroproteome study, peroxynitrite, prepared by chemical reaction, was mixed with KLH to form nitrated proteins to immunize rabbits. Nitrotyrosine antibodies were expressed by rabbit immunization. A capillary electrophoresis method was developed for validating the presence of 3-nitrotyrosine in nitrated proteins. The nitrated proteins in bile were visualized by 2D-PAGE-based western blotting. The interesting protein spots were identified by mass spectrometry. The functional analysis of nitrated haptoglobin was done by western blot and enhanced CL PAGE analysis. The haptoglobin phenotype of patients was also determined by enhanced CL PAGE analysis. By comparing the proteomic maps of different groups, two protein spots of elastase 3B were found highly expressed in the biliary cancer group. Three nitrated proteins were found less expressed in the biliary cancer group, and were matched to haptoglobin. The sites of nitrotyrosine in haptoglobin were located in haptoglobin β and α2 chains. The binding activity of haptoglobin-hemoglobin was decreased in nitrated haptoglobin. In analysis of haptoglobin phenotype distribution, the gallstone group had significantly higher Hp2 carrier than cholangiocarcinoma group (96% versus 86%, p<0.05). In conclusion, the map of bile proteins has been successfully established. Two candidates - elastase 3B and nitrated haptoglobin were found by proteomic analysis. Our observations suggest that elastase 3B may be a biomarker for biliary cancers and further study is needed to validate its clinical use. The detection of nitrate haptoglobin in bile suggest that reactive nitrogen species derived from nitric oxide might involve in the pathogenesis of biliary tract diseases. The studies of nitrated haptoglobin might be able to link nitrosative stress, hemoglobin metabolism, and biliary tract disease together.
Books on the topic "Biliary tract disease"
Johnson, A. G. Liver disease and gallstones: The facts. Oxford: Oxford University Press, 1987.
Find full textTalley, Nicholas Joseph, Keith D. Lindor, and Hugo E. Vargas. Practical gastroenterology and hepatology: Liver and biliary disease. Edited by Wiley online library. Chichester, West Sussex: Wiley-Blackwell, 2010.
Find full textSchwartz, J. Sanford. Biliary Tract Disease Patient Outcomes Research Team (PORT). [Philadelphia, PA]: Agency for Health Care Policy and Research, 1997.
Find full textSchwartz, J. Sanford. Biliary Tract Disease Patient Outcomes Research Team (PORT): Final report. Philadelphia, PA: Leonard Davis Institute of Health Economics and Dept. of Medicine, Univ. of Pennsylvania, 1997.
Find full textWright, Ralph. Liver and biliary disease: Pathophysiology, diagnoses, management. 2nd ed. London: Baillière Tildall, 1985.
Find full textC, Northfield T., ed. Bile acids in hepatobiliary disease: Proceedings of the Falk Workshop held in London, UK, 29-30 March 1999. Dordrecht: Kluwer Academic Publishers, 2000.
Find full textA, Summerfield John, ed. A colour atlas of liver disease. 2nd ed. St. Louis: Mosby Year Book, 1991.
Find full textHäussinger, D. Hepatobiliary transport in health and disease. Berlin: de Gruyter, 2012.
Find full textSherlock, Sheila. Diseases of the liver and biliary system. 8th ed. Oxford: Blackwell Scientific Publications, 1989.
Find full textBook chapters on the topic "Biliary tract disease"
Périssat, Jacques, David E. Pitcher, Daniel T. Martin, Karl A. Zucker, Jonathan M. Sackier, Mark A. Talamini, M. A. Röthlin, et al. "Biliary Tract Disease." In Principles of Laparoscopic Surgery, 109–70. New York, NY: Springer New York, 1995. http://dx.doi.org/10.1007/978-1-4612-2480-8_11.
Full textAugustin, Goran. "Acute Biliary Tract Disease." In Acute Abdomen During Pregnancy, 55–99. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-72995-4_2.
Full textVogelzang, R. L. "Percutaneous Cholecystostomy for Treatment of Benign Gallbladder Disease." In Biliary Tract Radiology, 177–88. Berlin, Heidelberg: Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-642-60343-3_15.
Full textGandini, G., M. C. Cassinis, P. Fonio, J. Maass, M. Natrella, and D. Righi. "Benign Biliary Disease: Management of Bile Duct Stones." In Biliary Tract Radiology, 245–59. Berlin, Heidelberg: Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-642-60343-3_21.
Full textCostamagna, G. "Role of Endoscopy in the Treatment of Benign Biliary Disease." In Biliary Tract Radiology, 233–44. Berlin, Heidelberg: Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-642-60343-3_20.
Full textPeters, Nils, Martin Dichgans, Sankar Surendran, Josep M. Argilés, Francisco J. López-Soriano, Sílvia Busquets, Klaus Dittmann, et al. "Congenital Biliary (Tract) Ectasia." In Encyclopedia of Molecular Mechanisms of Disease, 401. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_8188.
Full textHogan, Walter J., Wylie J. Dodds, and Joseph E. Geenen. "Abdominal Pain and Biliary Tract Dysmotility." In Pathogenesis of Functional Bowel Disease, 273–88. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4684-5694-3_13.
Full textSheka, Adam C., Keith M. Wirth, and Sayeed Ikramuddin. "Biliary Tract Disease in the Bariatric Surgery Patient." In The ASMBS Textbook of Bariatric Surgery, 505–14. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-27021-6_44.
Full textThistle, J. L., B. T. Petersen, J. E. McCullough, C. E. Bender, and A. J. LeRoy. "Local Litholytic Agents: Dissolution of Cholesterol Biliary Tract Stones with Methyl Tert-Butyl Ether." In Gallstone Disease, 205–9. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74619-2_24.
Full text"Biliary Tract Disease." In Swanson's Family Medicine Review: A Problem-Oriented Approach, 186–89. Elsevier, 2013. http://dx.doi.org/10.1016/b978-1-4557-0790-4.00036-6.
Full textConference papers on the topic "Biliary tract disease"
Lee, J., J. Mcdermott, and P. Dalvie. "Antegrade Percutaneous Transhepatic Biliary Endoscopy (APTBE) in the Management of Biliary Tract Disease." In Abstracts of 5th Annual Meeting of the American Society of Digestive Disease Interventions. Thieme Medical Publishers, 2019. http://dx.doi.org/10.1055/s-0039-1689018.
Full text